Loading clinical trials...

TERMINATEDPhase 2NCT04363827

Protect: Study With Hydroxychloroquine for Prevention and Early Phase Treatment of Coronavirus Disease (COVID-19)

This is a Italian, superiority, open label cluster-randomised, interventional clinical trial aimed at assessing whether the treatment with Hydroxychloroquine can reduce the percentage of symptomatic s...

Lead sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITING

Real World Evidence Study of SYN023 in Children Exposed to Rabies

NCT07327307 · Rabies Post-exposure Prophylaxis

RECRUITING

Monitoring of Anti-TFPI in Hemophilia

NCT07101926 · Hemophilia, Rebalancing Agents, and more

RECRUITINGPhase 3

A Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-010)

NCT07071623 · Human Immunodeficiency Virus (HIV), HIV Pre-Exposure Prophylaxis

RECRUITINGNA

PathToScale: The PERSIST Trial

NCT07221747 · Oral Pre-exposure Prophylaxis (PrEP), Long-acting Injectable Cabotegravir for PrEP

RECRUITINGPhase 2

Effect of 2-HOBA in Persistent Immune Activation in Long COVID POTS

NCT07189936 · Post-Acute COVID-19 Syndrome, Postural Tachycardia Syndrome (POTS), and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 10, 2025Terms

Trial snapshot

StatusTERMINATED

PhasePHASE2

Enrollment155

Start dateMay 2020

Last updatedMar 10, 2025

Condition

COVID19 Hydroxychloroquine Prophylaxis Treatment SARS-CoV-2

Locations shown

Irst Irccs

Meldola, FC

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 10, 2025Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions